Literature DB >> 3283848

The biology and pharmacology of PGD2.

H Giles1, P Leff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3283848     DOI： 10.1016/0090-6980(88)90093-7

Source DB:  PubMed          Journal:  Prostaglandins        ISSN： 0090-6980


× No keyword cloud information.
  33 in total

Review 1.  The diverse effects of mast cell mediators.

Authors:  Colleen Hines
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

2.  Identification and Molecular Characterization of Peroxisome Proliferator-Activated Receptor δ as a Novel Target for Covalent Modification by 15-Deoxy-Δ12,14-prostaglandin J2.

Authors:  Aravind T Reddy; Sowmya P Lakshmi; Asoka Banno; Raju C Reddy
Journal:  ACS Chem Biol       Date:  2018-11-29       Impact factor: 5.100

3.  Modification of the secretion pattern of proteases, inflammatory mediators, and extracellular matrix proteins by human aortic valve is key in severe aortic stenosis.

Authors:  Gloria Alvarez-Llamas; Tatiana Martín-Rojas; Fernando de la Cuesta; Enrique Calvo; Felix Gil-Dones; Veronica M Dardé; Luis F Lopez-Almodovar; Luis R Padial; Juan-Antonio Lopez; Fernando Vivanco; Maria G Barderas
Journal:  Mol Cell Proteomics       Date:  2013-05-23       Impact factor: 5.911

Review 4.  Prostanoid signaling: dual role for prostaglandin E2 in neurotoxicity.

Authors:  Dejan Milatovic; Thomas J Montine; Michael Aschner
Journal:  Neurotoxicology       Date:  2011-03-03       Impact factor: 4.294

5.  A comparative study of the prostanoid receptor profile of 9 alpha 11 beta-prostaglandin F2 and prostaglandin D2.

Authors:  H Giles; M L Bolofo; S J Lydford; G R Martin
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

6.  The role of prostanoid TP- and DP-receptors in the bronchoconstrictor effect of inhaled PGD2 in anaesthetized guinea-pigs: effect of the DP-antagonist BW A868C.

Authors:  S Hamid-Bloomfield; A N Payne; A A Petrovic; B J Whittle
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

7.  15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats.

Authors:  Y Kawahito; M Kondo; Y Tsubouchi; A Hashiramoto; D Bishop-Bailey; K Inoue; M Kohno; R Yamada; T Hla; H Sano
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

8.  Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemia.

Authors:  Farhat L Khanim; Rachel E Hayden; Jane Birtwistle; Alessia Lodi; Stefano Tiziani; Nicholas J Davies; Jon P Ride; Mark R Viant; Ulrich L Gunther; Joanne C Mountford; Heinrich Schrewe; Richard M Green; Jim A Murray; Mark T Drayson; Chris M Bunce
Journal:  PLoS One       Date:  2009-12-07       Impact factor: 3.240

9.  BAY u3405 an antagonist of thromboxane A2- and prostaglandin D2-induced bronchoconstriction in the guinea-pig.

Authors:  H P Francis; S J Greenham; U P Patel; A M Thompson; P J Gardiner
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

Review 10.  The mechanism and mitigation of niacin-induced flushing.

Authors:  V S Kamanna; S H Ganji; M L Kashyap
Journal:  Int J Clin Pract       Date:  2009-09       Impact factor: 2.503
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.